Form 8-K - Current report:
SEC Accession No. 0001683168-25-003838
Filing Date
2025-05-19
Accepted
2025-05-19 17:06:14
Documents
15
Period of Report
2025-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sunshine_8k.htm   iXBRL 8-K 27255
2 PRESS RELEASE sunshine_ex9901.htm EX-99.1 12936
3 GRAPHIC image_001.jpg GRAPHIC 6358
  Complete submission text file 0001683168-25-003838.txt   261971

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE sbfm-20250515.xsd EX-101.SCH 3552
5 XBRL DEFINITION FILE sbfm-20250515_def.xml EX-101.DEF 26584
6 XBRL LABEL FILE sbfm-20250515_lab.xml EX-101.LAB 36549
7 XBRL PRESENTATION FILE sbfm-20250515_pre.xml EX-101.PRE 25208
17 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_8k_htm.xml XML 5521
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-515-0810
Sunshine Biopharma Inc. (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41282 | Film No.: 25964962
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)